The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
Open Access
- 25 January 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell and tissue research
- Vol. 373 (1), 21-37
- https://doi.org/10.1007/s00441-017-2768-8
Abstract
Mitochondrial impairment is a well-established pathological pathway implicated in Parkinson’s disease (PD). Defects of the complex I of the mitochondrial respiratory chain have been found in post-mortem brains from sporadic PD patients. Furthermore, several disease-related genes are linked to mitochondrial pathways, such as PRKN, PINK1, DJ-1 and HTRA2 and are associated with mitochondrial impairment. This phenotype can be caused by the dysfunction of mitochondrial quality control machinery at different levels: molecular, organellar or cellular. Mitochondrial unfolded protein response represents the molecular level and implicates various chaperones and proteases. If the molecular level of quality control is not sufficient, the organellar level is required and involves mitophagy and mitochondrial-derived vesicles to sequester whole dysfunctional organelle or parts of it. Only when the impairment is too severe, does it lead to cell death via apoptosis, which defines the cellular level of quality control. Here, we review how currently known PD-linked genetic variants interfere with different levels of mitochondrial quality control. We discuss the graded risk concept of the most recently identified PARK loci (PARK 17–23) and some susceptibility variants in GBA, LRRK2 and SNCA. Finally, the emerging concept of rare genetic variants in candidates genes for PD, such as HSPA9, TRAP1 and RHOT1, complete the picture of the complex genetic architecture of PD that will direct future precision medicine approaches.Keywords
Funding Information
- Fonds National de la Recherche Luxembourg (FNR/P13/6682797/Krüger, NCER13/BM/11264123/NCER-PD/Rudi Balling)
This publication has 161 references indexed in Scilit:
- Genetic Variants of LRRK2 in Taiwanese Parkinson’s DiseasePLOS ONE, 2013
- Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s DiseaseCell Metabolism, 2013
- Impairment of Mitochondria in Adult Mouse Brain Overexpressing Predominantly Full-Length, N-Terminally Acetylated Human α-SynucleinPLOS ONE, 2013
- Translation Initiator EIF4G1 Mutations in Familial Parkinson DiseaseAmerican Journal of Human Genetics, 2011
- A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson DiseaseAmerican Journal of Human Genetics, 2011
- VPS35 Mutations in Parkinson DiseaseAmerican Journal of Human Genetics, 2011
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in SynucleinopathiesCell, 2011
- Replication of MAPT and SNCA, but not PARK16‐18, as susceptibility genes for Parkinson's diseaseMovement Disorders, 2011
- The Mechanism of Ca2+-Dependent Regulation of Kinesin-Mediated Mitochondrial MotilityCell, 2009
- Complex I deficiency in Parkinson's disease frontal cortexBrain Research, 2008